A judge questioned whether the president’s lawsuit against the IRS and Treasury can proceed with Trump effectively in control of both sides of the litigation.
While concerns remain about the profession’s pipeline of new accountants, Cathy Moy, chief people officer at BDO USA, sees plenty of ways to keep it full.
Eli Lilly is picking up Ajax Therapeutics and its once-daily oral blood cancer candidate. The deal follows the pharma’s buyouts of ADC specialist CrossBridge Bio and in vivo CAR T company Kelonia Therapeutics.
George Church’s Rejuvenate Bio is turning to social networks to help fund its work on one-time gene therapies targeting chronic diseases and root causes of aging.